Tomocube Launches 'HT-X1 Plus' to Accelerate Cell and Organoid Analysis
Tomocube (CEO Yonggeun Park, Kihyun Hong), a company specializing in three-dimensional label-free cell imaging, announced on the 4th that it has launched a new bioimaging platform called 'HT-X1 Plus.' HT-X1 Plus is the latest system designed to help researchers analyze cells and organoids faster and more precisely.
According to Tomocube, HT-X1 Plus offers a Field of View (FOV) that is four times wider than the previous model and enables high-speed scanning, significantly improving efficiency in large-scale experiments. It is also equipped with a high-performance fluorescence module based on sCMOS, greatly enhancing fluorescence imaging capabilities, allowing for more detailed analysis of cells and tissues. A particular strength is its integration with confocal microscopy, enabling precise analysis of complex biological samples.
Along with HT-X1 Plus, TomoAnalysis 2.0 was released, an advanced analysis software based on artificial intelligence. It includes 120 rule-based imaging modules and 7 AI-based imaging modules. Additionally, it offers 33 application-specific analysis logics, providing researchers with a wide range of functions to meet diverse analytical needs.
Lee Sumin, Director of Customer Development at Tomocube, stated, “HT-X1 Plus is an advanced model designed by actively incorporating feedback from existing users to maximize the advantages of holotomography (HT), which offers label-free three-dimensional high-resolution cell analysis. We expect HT technology to expand beyond the research market into industrial markets such as drug development, making significant contributions especially in non-clinical trial design.”
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, Tomocube stated that through HT-X1 Plus and TomoAnalysis 2.0, it provides high-performance bioimaging solutions that enable innovative analysis in the fields of three-dimensional biology, organoids, and regenerative medicine, thereby opening new horizons in the bioanalysis field.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
